Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, Randomized, Interventional, Study to Assess Subject Treatment Session Perception and Investigator Treatment Experience of Alluzience and Vacuum-Dried Botulinum Neurotoxin Type A for Aesthetic Use

NCT05277337 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT05277337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05277337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, Randomized, Interventional, Study to Assess Subject Treatment Session Perception and Investigator Treatment Experience of Alluzience and Vacuum-Dried Botulinum Neurotoxin Type A for Aesthetic Use
Lead sponsor
Galderma R&D
Phase
Phase 4
Overall status
Completed
Start date
February 4, 2022
Completion date
October 12, 2022
Enrollment
150 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

glabellar frown lines